Tutorials
PMV Pharmaceuticals Inc logo

PMV Pharmaceuticals Inc

$ 16.90 +0.72 (+4.45%) 08:09 PM EST
P/E:
At Loss
P/B:
2.78
Market Cap:
$ 771.02M
Enterprise V:
$ 506.18M
Volume:
604.71K
Avg Vol (2M):
1.08M
Volume:
604.71K
Market Cap $:
771.02M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.08M
Enterprise Value $:
506.18M
PB Ratio:
2.78
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

PMV Pharmaceuticals Inc
NAICS : 541714 SIC : 2833
8 Clarke Drive, Suite 3, Cranbury, NJ, USA, 08512
Description
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Name Current Vs Industry Vs History
Cash-To-Debt 22.03
Equity-to-Asset 0.92
Debt-to-Equity 0.05
Debt-to-EBITDA -0.18
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -29.3
3-Year EPS without NRI Growth Rate -31.6
3-Year FCF Growth Rate -28.5

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 59
9-Day RSI 58.25
14-Day RSI 57.38
6-1 Month Momentum % -0.49
12-1 Month Momentum % -52.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 24.76
Quick Ratio 24.76
Cash Ratio 24.37

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.3
Name Current Vs Industry Vs History
ROE % -22.44
ROA % -20.98
ROIC % -226.44
ROC (Joel Greenblatt) % -498.14
ROCE % -21.95

Financials (Next Earnings Date:2022-11-11 Est.)

PMVP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:PMVP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.52
Beta 0
Volatility % 66.35
14-Day RSI 57.38
14-Day ATR ($) 1.333155
20-Day SMA ($) 15.466
12-1 Month Momentum % -52.57
52-Week Range ($) 8.99 - 35.14
Shares Outstanding (Mil) 45.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PMV Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More